We are live on ! Find out more
ALXO icon

ALX Oncology
ALXO

96 hedge funds and large institutions have $622M invested in ALX Oncology in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more call options, than puts

Call options by funds: $444K | Put options by funds: $361K

0.95% more ownership

Funds ownership: 89.61% → 90.56% (+0.95%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 34

11% less funds holding

Funds holding: 108 → 96 (-12)

20% less capital invested

Capital invested by funds: $780M → $622M (-$158M)

52% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 21

Holders
96
Holders Change
-12
Holders Change %
-11.11%
% of All Funds
1.51%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
32
Reduced
34
Closed
21
Calls
$444K
Puts
$361K
Net Calls
+$83K
Net Calls Change
+$324K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.5M
2
State Street
State Street
Massachusetts
+$11.8M
3
O
OrbiMed
New York
+$7.07M
4
Deutsche Bank
Deutsche Bank
Germany
+$5.67M
5
SB
Samsara BioCapital
California
+$4.49M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$19.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$15.7M
3
Two Sigma Investments
Two Sigma Investments
New York
-$4.13M
4
Marshall Wace
Marshall Wace
United Kingdom
-$2.29M
5
Millennium Management
Millennium Management
New York
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
101
First Trust Advisors
Illinois
– -$468K -21,777 Closed
TC
102
TwinBeech Capital
New York
– -$462K -21,500 Closed
Qube Research & Technologies (QRT)
103
Qube Research & Technologies (QRT)
United Kingdom
– -$412K -19,190 Closed
AI
104
Atom Investors
Texas
– -$333K -15,477 Closed
PP
105
PDT Partners
New York
– -$326K -15,154 Closed
TRSOTSOK
106
Teachers Retirement System of the State of Kentucky
Kentucky
– -$247K -11,471 Closed
EGM
107
Engineers Gate Manager
New York
– -$230K -10,700 Closed
Manulife (Manufacturers Life Insurance)
108
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$212 -9,857 Closed
ProShare Advisors
109
ProShare Advisors
Maryland
– -$205K -9,579 Closed
EAM
110
Erste Asset Management
Austria
– -$202K -9,200 Closed
Zurich Cantonal Bank
111
Zurich Cantonal Bank
Switzerland
– -$13K -611 Closed
TWA
112
TCI Wealth Advisors
Arizona
– -$3K -131 Closed
AHIA
113
Andrew Hill Investment Advisors
Florida
– -$2K -100 Closed
AF
114
Allworth Financial
California
– +$171 +10 New
1 2 3 4
5

ALXO Hedge Fund Activity: Q1 2022 in Review

96 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q1 2022, worth a combined $622M — down 20% from $780M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ALXO and 10 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 32 added.

The largest buyer was Fidelity Investments, adding an estimated $16.5M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $19.8M sold.

  • 96 institutional investors held ALX Oncology (ALXO) as of Q1 2022, down from 108 in Q4 2021.
  • Funds reported $622M of ALX Oncology stock for Q1 2022, down 20% quarter-over-quarter.
  • 10 funds opened new ALX Oncology positions in Q1 2022 and 21 closed out, a net change of -11 holders.
  • The largest ALX Oncology buyer in Q1 2022 was Fidelity Investments, an estimated $16.5M added.
  • The largest ALX Oncology seller in Q1 2022 was Janus Henderson Group, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2022.